Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date	Form	Description	View
Mar 11, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-003476.pdf 0001179110-20-003476.rtf 0001179110-20-003476.xls
Mar 11, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-003473.pdf 0001179110-20-003473.rtf 0001179110-20-003473.xls
Mar 11, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-003474.pdf 0001179110-20-003474.rtf 0001179110-20-003474.xls
Mar 11, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-003475.pdf 0001179110-20-003475.rtf 0001179110-20-003475.xls
Mar 11, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-003478.pdf 0001179110-20-003478.rtf 0001179110-20-003478.xls
Mar 11, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-003477.pdf 0001179110-20-003477.rtf 0001179110-20-003477.xls
Mar 25, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-004115.pdf 0001179110-20-004115.rtf 0001179110-20-004115.xls
Mar 25, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-004114.pdf 0001179110-20-004114.rtf 0001179110-20-004114.xls
Apr 07, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-004742.pdf 0001179110-20-004742.rtf 0001179110-20-004742.xls
May 14, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-20-005993.pdf 0001179110-20-005993.rtf 0001179110-20-005993.xls

Continue